CHI3L1 plasma levels were significantly higher in COVID-19 patients at hospital admission (T0) than in HC (361.0 [152.9–988.8] ng/mL vs 82.4 [56.1–162.0] ng/mL, p < 0.0001, Fig. 1 panel A). Here, CHI3L1 is linked to COVID-19.